Management and treatment of glycogenosis type II.

B. Bembi, E. Cerini, C. Danesino, M. A. Donati, S. Gasperini, L. Morandi, O. Musumeci, G. Parenti, S. Ravaglia, F. Seidita, A. Toscano, A. Vianello

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Glycogenosis type II is a multisystem disorder that requires management by a multidisciplinary team. The team should include several specialists, such as a metabolic disease specialist or biochemical geneticist, cardiologist, pulmonologist, neurologist, neuromuscular specialist, intensivist, orthopedist, respiratory therapist, physical therapist, occupational therapist, otolaryngologist speech therapist, audiologist, genetic counselor, and a metabolic dietician, who, as a team, will be capable of addressing the different manifestations of the condition. Aspects of functional assessment, rehabilitation, nutritional management, care coordination, nursing, genetic counseling, prenatal diagnosis, and screening are discussed in this article. In addition, treatment of glycogenosis type II is reviewed with attention to emerging therapeutic options.

Original languageEnglish
JournalNeurology
Volume71
Issue number23 Suppl 2
DOIs
Publication statusPublished - Dec 2 2008

Fingerprint

Glycogen Storage Disease Type II
Prenatal Diagnosis
Nutrition Assessment
Nutritionists
Physical Therapists
Metabolic Diseases
Genetic Counseling
Nursing Care
Therapeutics
Rehabilitation

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Bembi, B., Cerini, E., Danesino, C., Donati, M. A., Gasperini, S., Morandi, L., ... Vianello, A. (2008). Management and treatment of glycogenosis type II. Neurology, 71(23 Suppl 2). https://doi.org/10.1212/WNL.0b013e31818da93f

Management and treatment of glycogenosis type II. / Bembi, B.; Cerini, E.; Danesino, C.; Donati, M. A.; Gasperini, S.; Morandi, L.; Musumeci, O.; Parenti, G.; Ravaglia, S.; Seidita, F.; Toscano, A.; Vianello, A.

In: Neurology, Vol. 71, No. 23 Suppl 2, 02.12.2008.

Research output: Contribution to journalArticle

Bembi, B, Cerini, E, Danesino, C, Donati, MA, Gasperini, S, Morandi, L, Musumeci, O, Parenti, G, Ravaglia, S, Seidita, F, Toscano, A & Vianello, A 2008, 'Management and treatment of glycogenosis type II.', Neurology, vol. 71, no. 23 Suppl 2. https://doi.org/10.1212/WNL.0b013e31818da93f
Bembi B, Cerini E, Danesino C, Donati MA, Gasperini S, Morandi L et al. Management and treatment of glycogenosis type II. Neurology. 2008 Dec 2;71(23 Suppl 2). https://doi.org/10.1212/WNL.0b013e31818da93f
Bembi, B. ; Cerini, E. ; Danesino, C. ; Donati, M. A. ; Gasperini, S. ; Morandi, L. ; Musumeci, O. ; Parenti, G. ; Ravaglia, S. ; Seidita, F. ; Toscano, A. ; Vianello, A. / Management and treatment of glycogenosis type II. In: Neurology. 2008 ; Vol. 71, No. 23 Suppl 2.
@article{63d4202cdcf841aba286aeb6456186b9,
title = "Management and treatment of glycogenosis type II.",
abstract = "Glycogenosis type II is a multisystem disorder that requires management by a multidisciplinary team. The team should include several specialists, such as a metabolic disease specialist or biochemical geneticist, cardiologist, pulmonologist, neurologist, neuromuscular specialist, intensivist, orthopedist, respiratory therapist, physical therapist, occupational therapist, otolaryngologist speech therapist, audiologist, genetic counselor, and a metabolic dietician, who, as a team, will be capable of addressing the different manifestations of the condition. Aspects of functional assessment, rehabilitation, nutritional management, care coordination, nursing, genetic counseling, prenatal diagnosis, and screening are discussed in this article. In addition, treatment of glycogenosis type II is reviewed with attention to emerging therapeutic options.",
author = "B. Bembi and E. Cerini and C. Danesino and Donati, {M. A.} and S. Gasperini and L. Morandi and O. Musumeci and G. Parenti and S. Ravaglia and F. Seidita and A. Toscano and A. Vianello",
year = "2008",
month = "12",
day = "2",
doi = "10.1212/WNL.0b013e31818da93f",
language = "English",
volume = "71",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "23 Suppl 2",

}

TY - JOUR

T1 - Management and treatment of glycogenosis type II.

AU - Bembi, B.

AU - Cerini, E.

AU - Danesino, C.

AU - Donati, M. A.

AU - Gasperini, S.

AU - Morandi, L.

AU - Musumeci, O.

AU - Parenti, G.

AU - Ravaglia, S.

AU - Seidita, F.

AU - Toscano, A.

AU - Vianello, A.

PY - 2008/12/2

Y1 - 2008/12/2

N2 - Glycogenosis type II is a multisystem disorder that requires management by a multidisciplinary team. The team should include several specialists, such as a metabolic disease specialist or biochemical geneticist, cardiologist, pulmonologist, neurologist, neuromuscular specialist, intensivist, orthopedist, respiratory therapist, physical therapist, occupational therapist, otolaryngologist speech therapist, audiologist, genetic counselor, and a metabolic dietician, who, as a team, will be capable of addressing the different manifestations of the condition. Aspects of functional assessment, rehabilitation, nutritional management, care coordination, nursing, genetic counseling, prenatal diagnosis, and screening are discussed in this article. In addition, treatment of glycogenosis type II is reviewed with attention to emerging therapeutic options.

AB - Glycogenosis type II is a multisystem disorder that requires management by a multidisciplinary team. The team should include several specialists, such as a metabolic disease specialist or biochemical geneticist, cardiologist, pulmonologist, neurologist, neuromuscular specialist, intensivist, orthopedist, respiratory therapist, physical therapist, occupational therapist, otolaryngologist speech therapist, audiologist, genetic counselor, and a metabolic dietician, who, as a team, will be capable of addressing the different manifestations of the condition. Aspects of functional assessment, rehabilitation, nutritional management, care coordination, nursing, genetic counseling, prenatal diagnosis, and screening are discussed in this article. In addition, treatment of glycogenosis type II is reviewed with attention to emerging therapeutic options.

UR - http://www.scopus.com/inward/record.url?scp=58149401853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149401853&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e31818da93f

DO - 10.1212/WNL.0b013e31818da93f

M3 - Article

C2 - 19047571

AN - SCOPUS:58149401853

VL - 71

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 23 Suppl 2

ER -